HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 55 filers reported holding HOOKIPA PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $208 | -30.0% | 337 | 0.0% | 0.00% | – |
Q2 2023 | $297 | +19.3% | 337 | -0.3% | 0.00% | – |
Q1 2023 | $249 | -54.7% | 338 | -50.2% | 0.00% | – |
Q4 2022 | $550 | -99.9% | 679 | -1.5% | 0.00% | – |
Q3 2022 | $923,000 | -62.0% | 689 | -53.7% | 0.00% | – |
Q2 2022 | $2,427,000 | -47.9% | 1,489 | -27.2% | 0.00% | – |
Q1 2022 | $4,660,000 | -55.8% | 2,044 | -54.8% | 0.00% | – |
Q4 2021 | $10,543,000 | -53.3% | 4,525 | +18.2% | 0.00% | – |
Q3 2021 | $22,553,000 | +169.7% | 3,829 | +319.4% | 0.00% | – |
Q2 2021 | $8,363,000 | -65.7% | 913 | -49.6% | 0.00% | – |
Q1 2021 | $24,358,000 | -22.1% | 1,811 | -35.8% | 0.00% | – |
Q4 2020 | $31,285,000 | -2.1% | 2,821 | -16.4% | 0.00% | – |
Q3 2020 | $31,942,000 | +292.1% | 3,373 | +381.2% | 0.00% | – |
Q2 2020 | $8,146,000 | -69.7% | 701 | -78.5% | 0.00% | – |
Q1 2020 | $26,912,000 | +44.6% | 3,262 | +114.3% | 0.00% | – |
Q4 2019 | $18,614,000 | +2286.4% | 1,522 | +1363.5% | 0.00% | – |
Q3 2019 | $780,000 | +1064.2% | 104 | +940.0% | 0.00% | – |
Q2 2019 | $67,000 | – | 10 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |